IL3RA and acute myeloid leukemia: We observed increased CD123 expression on the MOLM-13Luc AML cells in mice treated with AZA on days 8, 17, and 23 compared to PBS-treated mice (Fig. 3b–d and Supplementary Fig. 6e, f).